Quantum Genomics SA (ALQGC) — Cash Flow-to-Debt Ratio
Quantum Genomics SA (ALQGC) has a Cash Flow-to-Debt Ratio of -1.85x as of June 2023, meaning its operating cash flow of €-7.64 Million could theoretically repay -2% of its total liabilities (€4.13 Million) in one year. Explore Quantum Genomics SA strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Quantum Genomics SA Cash Flow-to-Debt Ratio (2012–2022)
Historical debt coverage capacity for Quantum Genomics SA across 11 annual periods. Also explore Quantum Genomics SA (ALQGC) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Quantum Genomics SA (2012–2022)
Year-by-year debt coverage analysis for Quantum Genomics SA. For market capitalisation and broader financial context, see Quantum Genomics SA (ALQGC) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.01x | €-20.21 Million | €20.05 Million | ▲ +31.4% |
| 2021 | -1.47x | €-17.02 Million | €11.57 Million | ▲ +0.1% |
| 2020 | -1.47x | €-11.99 Million | €8.15 Million | ▲ +24.2% |
| 2019 | -1.94x | €-10.43 Million | €5.37 Million | ▼ -17.7% |
| 2018 | -1.65x | €-10.90 Million | €6.61 Million | ▼ -4.3% |
| 2017 | -1.58x | €-7.98 Million | €5.05 Million | ▲ +22.3% |
| 2016 | -2.04x | €-5.53 Million | €2.72 Million | ▼ -63.2% |
| 2015 | -1.25x | €-3.14 Million | €2.52 Million | ▼ -118.3% |
| 2014 | -0.57x | €-2.79 Million | €4.88 Million | ▼ -92.4% |
| 2013 | -0.30x | €-987.00K | €3.32 Million | ▲ +4.4% |
| 2012 | -0.31x | €-614.00K | €1.97 Million | — |